Some visit links earn us a commission.

Foundayo vs Wegovy pill cost: both $149 a month and up

Prices checked November 16, 2026

No insurance needed. Two programs to check.

Foundayo and the Wegovy pill are the two once-a-day pills approved for weight loss, from two makers and with two different medicines. Foundayo is orforglipron from Eli Lilly; the Wegovy pill is semaglutide from Novo Nordisk. Both start at $149 a month paying cash, and the prices part at the top doses.

Foundayo vs Wegovy pill, side by side

Foundayo and Wegovy pill compared on medicine, approval, cash price, savings card, Medicare and doses
FoundayoWegovy pill
Medicine
OrforglipronSemaglutide
Sold for cash by
LillyDirect (Eli Lilly)NovoCare (Novo Nordisk)
Approved for
Weight lossWeight loss
Cash price
$149 at 0.8 mg; $149 at 2.5 mg until December 31, 2026, then $199; $199 at 5.5 mg until December 31, 2026, then $299; $299 at 9 mg; $349 at 14.5 mg and 17.2 mg, or $299 if you refill within 45 days of your last delivery$149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg
Savings card, with commercial insurance
As low as $25 for a 1, 2 or 3-month Rx (annual max $1,000), until December 31, 2026As low as $25/mo (max $100/mo off)
Doses
0.8 mg once daily for at least 30 days, then 2.5 mg, then 5.5 mg, then 9 mg, 14.5 mg or 17.2 mg, each after at least 30 days25 mg daily. Highest dose 25 mg daily

Cash prices are the makers' own, checked November 16. You need a prescription for either.

Price by dose

Lilly sells Foundayo direct at $149 at 0.8 mg; $149 at 2.5 mg until December 31, 2026, then $199; $199 at 5.5 mg until December 31, 2026, then $299; $299 at 9 mg; $349 at 14.5 mg and 17.2 mg, or $299 if you refill within 45 days of your last delivery. A month is a 30 days supply. Novo Nordisk sells the Wegovy pill through NovoCare at $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg.

At the doses people stay on, the Wegovy pill's 9 mg and 25 mg are $299 a month. Foundayo's 14.5 mg and 17.2 mg doses are $349, or $299 when you refill within 45 days of your last delivery. Every Foundayo dose: Foundayo cost. Every Wegovy pill dose: Wegovy pill cost.

What changes after December 31, 2026

Lilly cut two Foundayo doses until December 31, 2026: 2.5 mg is $149 now and goes back to $199, and 5.5 mg is $199 now and goes back to $299.

NovoCare's Wegovy pill prices carry no end date on the record we read.

Insurance, Medicare and the savings cards

Both are weight loss drugs, so a plan pays only where it covers weight loss, usually after prior approval. With commercial insurance that covers the drug, Foundayo's card terms read as low as $25 for a 1, 2 or 3-month Rx (annual max $1,000), until December 31, 2026. Wegovy's read as low as $25/mo (max $100/mo off). Neither card works with Medicare or Medicaid.

On Medicare, the GLP-1 Bridge charges $50 a month for Foundayo to Part D members who qualify, from July 1, 2026 to December 31, 2027.

What the clinical trials found

In ATTAIN-1, people on Foundayo's top dose lost 11.1 percent of body weight on average at 17.2 mg over 72 weeks, against 2.1 percent on placebo. In OASIS 4, people on the Wegovy pill lost 13.6 percent of body weight on average at 25 mg over 64 weeks, against 2.2 percent on placebo.

These were separate clinical trials in different groups of people, so the two figures are not a head-to-head result. Your prescriber picks the pill and the dose.

Questions people ask

Is Foundayo cheaper than the Wegovy pill?
Both start at $149 a month. At the top doses Foundayo is $349, or $299 with a refill within 45 days, and the Wegovy pill $299.
Will Foundayo cost more after December 31, 2026?
At two doses. 2.5 mg goes from $149 to $199 and 5.5 mg goes from $199 to $299 a month.
Are Foundayo and the Wegovy pill the same drug?
No. Foundayo is orforglipron from Eli Lilly and the Wegovy pill is semaglutide from Novo Nordisk. Both are taken once a day for weight loss.
Which pill causes more weight loss?
In their own trials, Foundayo's top dose took off 11.1 percent of body weight over 72 weeks and the Wegovy pill 13.6 percent over 64 weeks. They were not tested against each other.

Compare other GLP-1 medications

Sources

Evidence checked November 9, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

4 documents

  1. What Foundayo is approved for and its dosesFDA prescribing information for Foundayo (DailyMed, August 2026)
  2. What Wegovy pill is approved for and its dosesFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
  3. ATTAIN-1: 11.1 percent of body weight on average at 17.2 mg over 72 weeks, against 2.1 percent on placeboWharton S et al. N Engl J Med 2025;393(18):1796-1806
  4. OASIS 4: 13.6 percent of body weight on average at 25 mg over 64 weeks, against 2.2 percent on placeboWharton S et al. N Engl J Med 2025;393(11):1077-1087

Prices from NovoCare and LillyDirect and the makers' savings card pages, checked November 16. How we check prices.